Objective: To better understand the impact of a microscopically positive margin (R1) on patterns of disease recurrence and survival after pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma. Summary Background Data: A positive resection margin after PD is considered to be a poor prognostic factor, and some have proposed that an R1 margin may be a biologic predictor of more aggressive disease. The natural history of patients treated with contemporary multimodality therapy who underwent a positive margin PD has not been described. Methods: We analyzed our experience from 1990 to 2004, which included the prospective use of a standardized system for pathologic analysis of all PD specimens. All patients who underwent PD met objective comp...
Pancreatic cancer is associated with a poor prognosis. While surgical resection is the only treatmen...
Further collaborating authors listed after main articleBackground: R0 resection rates (complete tumo...
BACKGROUND: Resectable pancreatic ductal adenocarcinoma continues to carry a poor prognosis. Of the ...
OBJECTIVE: To better understand the impact of a microscopically positive margin (R1) on patterns of ...
Background: The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is poor and selec...
Objective: To determine the prognostic influence of residual tumor at or within 1 mm of the mobiliza...
Objective and Background: Local and distant disease recurrence are frequently observed following pa...
Introduction: First, this study aimed to assess the prognostic value of different definitions for re...
Introduction: First, this study aimed to assess the prognostic value of different definitions for re...
Design: It was the aim of this study to investigate the influence of extended retroperitoneal tissue...
Purpose: Current adjuvant therapies for pancreatic cancer (PC) are inconsistently used and only mode...
Full list of author information is available at the end of the articleBackground Pancreatic ductal a...
Resection margin status and lymph node (LN) involvement are known prognostic factors for patients wh...
Context Patients with resectable pancreatic cancer comprise a small subgroup of the overall populati...
Background: The optimal definition of a margin-negative resection and its exact prognostic significa...
Pancreatic cancer is associated with a poor prognosis. While surgical resection is the only treatmen...
Further collaborating authors listed after main articleBackground: R0 resection rates (complete tumo...
BACKGROUND: Resectable pancreatic ductal adenocarcinoma continues to carry a poor prognosis. Of the ...
OBJECTIVE: To better understand the impact of a microscopically positive margin (R1) on patterns of ...
Background: The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is poor and selec...
Objective: To determine the prognostic influence of residual tumor at or within 1 mm of the mobiliza...
Objective and Background: Local and distant disease recurrence are frequently observed following pa...
Introduction: First, this study aimed to assess the prognostic value of different definitions for re...
Introduction: First, this study aimed to assess the prognostic value of different definitions for re...
Design: It was the aim of this study to investigate the influence of extended retroperitoneal tissue...
Purpose: Current adjuvant therapies for pancreatic cancer (PC) are inconsistently used and only mode...
Full list of author information is available at the end of the articleBackground Pancreatic ductal a...
Resection margin status and lymph node (LN) involvement are known prognostic factors for patients wh...
Context Patients with resectable pancreatic cancer comprise a small subgroup of the overall populati...
Background: The optimal definition of a margin-negative resection and its exact prognostic significa...
Pancreatic cancer is associated with a poor prognosis. While surgical resection is the only treatmen...
Further collaborating authors listed after main articleBackground: R0 resection rates (complete tumo...
BACKGROUND: Resectable pancreatic ductal adenocarcinoma continues to carry a poor prognosis. Of the ...